Ce diaporama a bien été signalé.
Le téléchargement de votre SlideShare est en cours. ×

Johnson & Johnson

Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Chargement dans…3
×

Consultez-les par la suite

1 sur 23 Publicité

Plus De Contenu Connexe

Diaporamas pour vous (20)

Similaire à Johnson & Johnson (20)

Publicité

Plus par Md. Shahadat Hossain (14)

Plus récents (20)

Publicité

Johnson & Johnson

  1. 1. 1
  2. 2. 2 GROUP NAME”UNITY” Section: B Name ID 1. Md. Ashikur Rahman 14102383 2. Md. Shahadat Hossain 13102357 3. Rimi Shaha 14102166 4. Afruja Akter Asha 14102331 5. Anjuman Bushra Prome 15102034
  3. 3. Proposed Slogan 3 “Caring for you from the beginning, to the very end!”
  4. 4. History 4  1886- 3 brothers founded Johnson & Johnson in Brunswick, New Jersey.  1888- Pioneered the first commercial First Aid Kit.  1894- Launches first maternity kit to make child birth safer  1898- First to mass produce dental floss.  1921- An employee invents the first BAND-AID  1937- Began international expansion with companies in Argentina & Brazil  1954- Baby shampoo enter the market  1978- The Company begins construction on their new World Headquarters in New Jersey.  1990’s- Ethicon Endo-Surgery pioneers minimally invasive surgery.  2002- Johnson & Johnson acquires Tibotec-Virco BVBA  2006- Johnson & Johnson acquires Pfizer Consumer Healthcare  2009- Acquisition of Mentor Corporation
  5. 5. 5 Vision Statement To continue on the path set forth by the founders of Johnson's Enterprises, by committing ourselves to our clients and employees and also contributing to the community. Mission Statement To provide our clients with the best possible service and product, which meet our demands on quality and safety regulations, by assuring that our employees have all the necessary tools, training and expertise to accomplish their given tasks? Objective: To provide the high quality services and products in cure disease. To improve the quality of life. To be the leaders in the customer satisfaction. To motivating peoples for using or attracting their product.
  6. 6. Organizational Chart 6
  7. 7. Current situation 7 Worldwide sales for the full-year 2016 were $71.9 billion, an increase of 2.6% versus 2015. Operational results increased 3.9% and the negative impact of currency was 1.3%. Domestic sales increased 6.0%. International sales decreased 0.9%, reflecting operational growth of 1.8% and a negative currency impact of 2.7%. The additional shipping days in 2015 negatively impacted the current year by 130 basis points. worldwide sales increased 7.4%, domestic sales increased 8.9% and international sales increased 5.7%.
  8. 8. 8 External Environment: General Environment Political Environment Economic Environment Social Environment Internal Environment Corporate structure Corporate culture
  9. 9. 9 Organizational activities analysis of Johnson and Johnson Marketing of Johnson and Johnson Products Place Price Promotion
  10. 10. 10 Market Analysis: J&J COV P & G NVS UN Market Cap: US$ 253.06B 28.41B 217.48B 184.02B 111.80B Employees: 127,600 43,400 121,000 131,000 173,000 Qtrly Rev Growth (yoy): 0.09 0.02 0.02 0.01 0.00 Revenue (ttm): 69.99B 12.14B 84.17B 57.96B 66.58B Gross Margin (ttm): 0.69 0.57 0.50 0.68 0.40 EBITDA (ttm): 22.74B 3.33B 18.73B 17.10B 10.75B Operating Margin (ttm): 0.27 0.22 0.19 0.21 0.14 Net Income (ttm): 12.86B 1.90B 11.07B 9.52B 6.19B EPS (ttm): 4.51 3.77 3.86 3.86 2.12 P/E (ttm): 19.93 16.40 20.57 19.47 18.56 PEG (5 yr expected): 2.71 1.92 2.21 3.15 9.59 P/S (ttm): 3.62 2.34 2.58 3.17 1.68
  11. 11. 11 Competitive advantage Product Brand Innovation Extensive collaboration Research & Development Porter’s Five Forces
  12. 12. 12 Value Chain
  13. 13. 13 SWOT Matrix Strengths Weaknesses •A Substantial Marketing Arsenal •Strategic Acquisitions •Product Diversification •Positive Revenue Growth Projections •Significant sales and marketing capability. •Forecast growth despite challenges. •Dependence upon the Success of Launch Products •Reliance on Small Molecule Drugs •Theft and countering drugs from internal staff as much as this is not isolated. •Key product demand is shrinking. Opportunities Threats •Wide Range of Potential Cross-selling Opportunities •Potential to Exploit Biologics Market •Global Expansion •Economic recovery will be a boost in income thus company revenue will increase. •R & D investment will add to the potential growth rate of the company in surrounding markets. •Dependence on the Success of Launch Products •Negative Impact of Recent Product Recalls •Healthcare regulations •Better research and development of competitors •Low market growth rate.
  14. 14. 14 Internal Factors Evaluation (IFE) Matrix Key Internal Factors Weight Rating Weighted Score Internal Strengths 1. Diverse business offering 0.09 3 0.27 2. Forecast growth despite challenges. 0.08 3 0.24 3. Significant sales and marketing capability. 0.1 3 0.3 4. Robust financial position. 0.1 4 0.4 5. They gave strong global prescience operating in more than 57 countries with 250 subsidiaries companies. 0.08 4 0.32 6. They have successfully employed strategies to differentiation that helps it distinguish its self competitors. 0.08 4 0.32 Internal Weakness 1. Generic drug’s exposure. 0.08 2 0.16 2. Private label exposure. 0.08 2 0.16 3. Quality issues in OTC products affecting consumer healthcare product. 0.07 2 0.14 4. Key product demand is shrinking. 0.07 1 0.07 5. Theft and countering drugs from internal staff as much as this is not isolated. 0.09 2 0.18 6. Pressure to reduce prices in accordance with medical budgets and maintain patent expirations to help generic programs. 0.08 2 0.16 Total 1.00 2.72
  15. 15. 15 External Factor Evaluation (EFE) Matrix: Key External Factors Weight Rating Weighted Score External Opportunities 1. Acquisition of Synthesis could chance J & J failure of prospective products to deliver leadership position in global orthopedics market. 0.07 2 0.14 2. Leveraging therapeutic coverage of non-prescription pharmaceutical segments could provide cross selling opportunities. 0.09 2 0.18 3. Addition of Crucell to broden J & J position in biologics and vaccines market. 0.11 3 0.33 4. R & D investment will add to the potential growth rate of the company in surrounding markets. 0.07 2 0.14 5. Economic recovery will be a boost in income thus company revenue will increase. 0.10 3 0.3 6. Global Expansion 0.06 4 0.24 External Threats 1. Negative impact of recent product recalls 0.09 3 0.27 2. Healthcare regulations 0.09 2 0.18 3. Better research and development of competitors 0.08 2 0.16 4. Low market growth rate. 0.06 2 0.12 5. Strong competition from generic market. 0.10 3 0.3 6. Launch success in that newly launch products are uncertain because of regulatory review, thus making the launch a potential threat if it fails. 0.08 3 0.24 Total 1.00 2.60
  16. 16. TWOS Matrix 16 SO Strategies •S1, O1: JNJ Should aim to be an industry leader in all its diverse business offerings. •S2, O2: With the addition of new products in various departments, JNJ could potentially still predict growth in challenging times. WO Strategies •W1, O1: Although there is a wide variety of generic drugs, JNJ should use this as an opportunity to highlight the value and quality of their products and increase R&D in specific segments to increase market share in surrounding markets. •W2, O2: OTC sales should be used as a prime opportunity to highlight the value and worth of JNJ`s products. ST Strategies •S1, T1: JNJ`s diversity should not be a means for its products to be valued as "average", its diversified range should be known for the high quality. •S2, T2: The prediction of increased sales in challenging times should be a testament to JNJ`s value and quality of products. WT Strategies •W1, T1: Product recalls can seriously hinder the perceived value and quality of JNJ. •W2, T2: Healthcare regulations along with challenging economic times can prove costly to JNJ as a whole.
  17. 17. 17 Strategic Decision Alternative Strategy 1 Alternative Strategy 2 Alternative Strategy 3 Alternative Strategy 4
  18. 18. 18 Advantages of Alternative Strategy 1: Addition of new products in various departments High quality Disadvantages of Alternative Strategy 1:  Very challenging High cost Advantages of Alternative Strategy 2: increasing R&D increasing market share Disadvantages of Alternative Strategy 2: challenging economic Maintain rules and regulation
  19. 19. 19 Recommendation J&J should take alternative strategy 1 and 2.If they take this strategy than they can merge With the addition of new products in various departments, J&J could potentially still predict growth in challenging times. And if they take alternative 2 than increase R&D in specific segments to increase market share in surrounding markets.OTC sales should be used as a prime opportunity to highlight the value and worth of J&J`s products.
  20. 20. 20 Evaluation & Control: Area of objective Short Term Responsibility Customers 1. Image Well-recognized in their pharmaceuticals division and process from there. Marketing 2. Customer relation Customer should feel they have more of an influence and say over the J&J products and expectation. Public Relations 3. Increase OTC sales Will help boost sales Sales Learning & growth 1. System maintenance upgrades Important to maintain and continuously be running the latest and up to date technology. IT department 2.Training & development Train new employees and update experienced workers. Managers 3. Funding allocation Important to wisely select division which need more funding than others. Managers Operation/Internal process 1. Controlling and managing materials Should be controlled and well organized for distribution Managers/Employees 2. Procurement of materials Manager should make sure they are getting materials and equipment for best possible cost. Management 3. Distribution of materials Delivery time-frame should be met within specified days. Management Financial 1.Decrease R&D expense Decrease R&D expense as a whole but fund certain division more than others for the time being. Management 2. Increase net sales Conservative approach, yet avoid defensive strategy Management/Sales Department
  21. 21. 21 Possible Issues •Additional product recalls/ lawsuits. •Another economic downturn. •Competitor’s gaining market share. •Federal regulations that affect potential new products and existing processes. •Litigation from people being hurt through defective products. •International regulations that limit foreign expansion.
  22. 22. 22 CONCLUSION The “Johnson & Johnson” company is so omnipresent in the market that without it even the world of the baby products and health care product sounds incomplete. They believe their first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use Johnson and Johnson products and services. In meeting their needs everything they do are in high quality. When we talk about baby products Johnson and Johnson products is what comes first in our mind. Everything related to the brand, be its advertisements, products, after sale services are all example of perfect excellence.
  23. 23. Questions? 23

×